ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

LIPO Lipella Pharmaceuticals Inc

0.742
-0.008 (-1.07%)
최종 업데이트: 22:49:13
15분 지연
기업명 주식 심볼 시장 주식 타입
Lipella Pharmaceuticals Inc LIPO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.008 -1.07% 0.742 22:49:13
개장가 저가 고가 종가 전일 종가
0.796 0.742 0.796 0.75
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202421:00GLOBELipella Pharmaceuticals Expands its Advisory Board to..
05/04/202421:00GLOBELipella Pharmaceuticals to Publish Abstract Detailing..
03/04/202421:00GLOBELipella Pharmaceuticals Announces FDA Type C Meeting for..
08/03/202405:23GLOBEPRISM MarketView Spotlights Lipella Pharmaceuticals as it..
07/03/202407:05EDGAR2Form SC 13D/A - General statement of acquisition of..
07/03/202407:03EDGAR2Form SC 13D/A - General statement of acquisition of..
05/03/202422:00GLOBELipella Pharmaceuticals Announces FDA Clearance of IND for..
28/02/202407:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/02/202406:51EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/02/202422:00GLOBELipella Pharmaceuticals to Present at PropThink Digital..
09/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
08/02/202407:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/02/202406:09EDGAR2Form S-3 - Registration statement under Securities Act of..
26/01/202406:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04/01/202406:59EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/12/202322:00GLOBELipella Pharmaceuticals Marks Successful First Year with..
29/11/202307:28EDGAR2Form 8-K - Current report
23/11/202306:05EDGAR2Form 8-K - Current report
14/11/202320:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202320:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202322:00PRNUSFDA Grants Orphan Designation for Lipella's LP-310 Drug..
10/11/202306:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/11/202305:06EDGAR2Form S-1 - General form for registration of securities under..
26/10/202305:05PRNUSLipella Pharmaceuticals Announces Closing of $2 Million..
24/10/202321:00PRNUSLipella Pharmaceuticals Announces $2 Million Private..
20/10/202321:00PRNUSLipella Pharmaceuticals Announces FDA Clearance of IND for..
11/10/202305:05EDGAR2Form DEF 14A - Other definitive proxy statements
21/09/202321:30PRNUSLipella Pharmaceuticals' Phase 2a Clinical Study Results..
11/09/202320:38EDGAR2Form 8-K - Current report
15/08/202305:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/08/202305:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:30EDGAR2Form 8-K - Current report
03/08/202305:05EDGAR2Form 8-K - Current report
15/05/202322:17PRNUSLipella Pharmaceuticals Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock